These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3360 related articles for article (PubMed ID: 30737476)

  • 1. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
    Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
    Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
    Xu Y; Li X; Cheng Y; Yang M; Wang R
    FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
    Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
    Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia-inhibited ferric chelate reductase 1 improves ferroptosis-mediated intestinal ischemia injury via Hippo signaling.
    Liang P; Xie W; Wang X; Du Z; Zheng C; Zhao H; Wang Z; Ji Z
    Int Immunopharmacol; 2024 May; 132():111900. PubMed ID: 38531200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tongqiao Huoxue Decoction inhibits ferroptosis by facilitating ACSL4 ubiquitination degradation for neuroprotection against cerebral ischemia-reperfusion injury.
    Ou Z; Deng Y; Wu Y; Wang Y; Zhao Y; Liu C; Wang Z; Liu M; Hu X; Fang L; Chen J
    Phytomedicine; 2024 Jul; 130():155701. PubMed ID: 38788392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MitoQ protects against carbon tetrachloride-induced hepatocyte ferroptosis and acute liver injury by suppressing mtROS-mediated ACSL4 upregulation.
    Tao L; Xue YF; Sun FF; He X; Wang HQ; Tong CC; Zhang C; Xu DX; Chen X
    Toxicol Appl Pharmacol; 2024 May; 486():116914. PubMed ID: 38522585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbated ischemia-reperfusion injury in fatty livers is mediated by lipid peroxidation stress and ferroptosis.
    Rokop ZP; Zhang W; Ghosh N; Biswas N; Das A; Lin J; Sen CK; Kubal C
    Surgery; 2024 Jun; 175(6):1539-1546. PubMed ID: 38508920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Acyl-CoA Synthetase Long-Chain Family Member 4 Facilitates Neurological Recovery After Stroke by Regulation Ferroptosis.
    Chen J; Yang L; Geng L; He J; Chen L; Sun Q; Zhao J; Wang X
    Front Cell Neurosci; 2021; 15():632354. PubMed ID: 33889074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury.
    Li Y; Cao Y; Xiao J; Shang J; Tan Q; Ping F; Huang W; Wu F; Zhang H; Zhang X
    Cell Death Differ; 2020 Sep; 27(9):2635-2650. PubMed ID: 32203170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cisplatin-induced Acsl4-mediated ferroptosis alleviated ovarian injury.
    Wang S; Li X; Li J; Wang A; Li F; Hu H; Long T; Pei X; Li H; Zhong F; Zhu F
    Chem Biol Interact; 2024 Jan; 387():110825. PubMed ID: 38056807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
    He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion.
    Tuo QZ; Liu Y; Xiang Z; Yan HF; Zou T; Shu Y; Ding XL; Zou JJ; Xu S; Tang F; Gong YQ; Li XL; Guo YJ; Zheng ZY; Deng AP; Yang ZZ; Li WJ; Zhang ST; Ayton S; Bush AI; Xu H; Dai L; Dong B; Lei P
    Signal Transduct Target Ther; 2022 Feb; 7(1):59. PubMed ID: 35197442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation.
    Cui Y; Zhang Y; Zhao X; Shao L; Liu G; Sun C; Xu R; Zhang Z
    Brain Behav Immun; 2021 Mar; 93():312-321. PubMed ID: 33444733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enriched Environment Attenuates Ferroptosis after Cerebral Ischemia/Reperfusion Injury via the HIF-1
    Liu J; Luo Q; Ke J; Zhang D; Xu Y; Liao W; Chen X; Zhang X
    Oxid Med Cell Longev; 2023; 2023():5157417. PubMed ID: 36819784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4
    Tao WH; Shan XS; Zhang JX; Liu HY; Wang BY; Wei X; Zhang M; Peng K; Ding J; Xu SX; Li LG; Hu JK; Meng XW; Ji FH
    Front Pharmacol; 2022; 13():782466. PubMed ID: 35873574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis.
    Shi L; Song Z; Li Y; Huang J; Zhao F; Luo Y; Wang J; Deng F; Shadekejiang H; Zhang M; Dong S; Wu X; Zhu J
    Am J Transplant; 2023 Jan; 23(1):11-25. PubMed ID: 36695612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
    Dai Y; Chen Y; Mo D; Jin R; Huang Y; Zhang L; Zhang C; Gao H; Yan Q
    Commun Biol; 2023 Sep; 6(1):907. PubMed ID: 37670055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.
    Zhang HL; Hu BX; Li ZL; Du T; Shan JL; Ye ZP; Peng XD; Li X; Huang Y; Zhu XY; Chen YH; Feng GK; Yang D; Deng R; Zhu XF
    Nat Cell Biol; 2022 Jan; 24(1):88-98. PubMed ID: 35027735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
    Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
    Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
    Yuan H; Li X; Zhang X; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 168.